Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2017
At a glance
- Drugs ANB 020 (Primary)
- Indications Asthma; Peanut hypersensitivity
- Focus Proof of concept; Therapeutic Use
- Sponsors AnaptysBio
- 11 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
- 11 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
- 10 Oct 2017 According to an AnaptysBio media release, top-line data from this study are expected in the fourth quarter of 2017.